191,579 Indivior PLC $INDV Shares Bought by Two Seas Capital LP

Two Seas Capital LP lifted its stake in shares of Indivior PLC (NASDAQ:INDV) by 5.5% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,671,072 shares of the company’s stock after acquiring an additional 191,579 shares during the period. Indivior accounts for about 1.5% of Two Seas Capital LP’s portfolio, making the stock its 8th largest position. Two Seas Capital LP owned approximately 3.11% of Indivior worth $131,608,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also bought and sold shares of the stock. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Indivior in the fourth quarter valued at $82,687,000. Assenagon Asset Management S.A. acquired a new stake in shares of Indivior in the 2nd quarter valued at about $63,224,000. Newtyn Management LLC acquired a new stake in shares of Indivior in the 2nd quarter valued at about $53,577,000. Hennion & Walsh Asset Management Inc. bought a new stake in Indivior in the 2nd quarter valued at about $14,781,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in Indivior during the 2nd quarter worth approximately $7,988,000. 60.33% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

INDV has been the subject of a number of research reports. Craig Hallum reissued a “buy” rating and issued a $53.00 price objective on shares of Indivior in a research note on Tuesday, August 4th. Barclays cut their target price on Indivior from $46.00 to $43.00 and set an “overweight” rating on the stock in a report on Wednesday, August 5th. Zacks Research upgraded shares of Indivior from a “hold” rating to a “strong-buy” rating in a report on Friday. Finally, Weiss Ratings lowered shares of Indivior from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, September 24th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average price target of $45.17.

Indivior Stock Performance

INDV traded down $0.09 during mid-day trading on Tuesday, reaching $35.90. 2,390,473 shares of the stock were exchanged, compared to its average volume of 2,173,062. Indivior PLC has a 1 year low of $22.78 and a 1 year high of $42.81. The stock has a market capitalization of $4.24 billion, a PE ratio of 12.87 and a beta of 0.87. The company has a 50 day moving average price of $36.63 and a two-hundred day moving average price of $36.44.

Indivior (NASDAQ:INDV) last announced its earnings results on Tuesday, June 30th. The company reported $5.75 EPS for the quarter. Indivior had a net margin of 26.65% and a negative return on equity of 283.11%. The company had revenue of $343.00 million during the quarter. Sell-side analysts expect that Indivior PLC will post 3.66 EPS for the current fiscal year.

Indivior Dividend Announcement

The firm also recently announced a special dividend, which will be paid on Friday, November 6th. Stockholders of record on Friday, October 30th will be paid a $8.13 dividend. The ex-dividend date is Friday, October 30th.

Insider Buying and Selling

In other news, insider Christian Heidbreder sold 18,586 shares of the company’s stock in a transaction that occurred on Friday, July 10th. The stock was sold at an average price of $41.14, for a total value of $764,628.04. Following the completion of the transaction, the insider directly owned 209,337 shares of the company’s stock, valued at $8,612,124.18. This represents a 8.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Woodrow D. Anderson acquired 1,500 shares of the business’s stock in a transaction on Thursday, August 27th. The stock was acquired at an average cost of $35.69 per share, for a total transaction of $53,535.00. Following the transaction, the chief accounting officer owned 27,638 shares of the company’s stock, valued at approximately $986,400.22. The trade was a 5.74% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.74% of the stock is owned by insiders.

Indivior Profile

Indivior PLC (NASDAQ: INDV) is a specialty pharmaceutical company focused on developing and commercializing treatments for substance use disorders and serious mental health conditions. The company’s primary focus is opioid use disorder, with products designed to support patients through medication-assisted treatment and recovery.

Indivior’s portfolio includes Sublocade, an extended-release injectable formulation of buprenorphine; Suboxone, a buprenorphine and naloxone product available in sublingual formulations; and Perseris, an extended-release injectable formulation of risperidone for schizophrenia.